欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/0002/024
药品名称Ultratard
活性成分
    • insulin human (rDNA) 10 ml 100.0 IU/ml
剂型Suspension for injection
上市许可持有人Novo Nordisk A/S Novo Alle DK-2880 Bagsv?rd
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Germany (DE)
      Ultratard
    • Belgium (BE)
      Ultratard
    • Netherlands (NL)
      Ultratard
    • Luxembourg (LU)
      Insulines
    • United Kingdom (Northern Ireland) (XI)
      Ultratard
    • Ireland (IE)
      Ultratard
    • Austria (AT)
      Insulin "Novo Nordisk" Ultratard HM 100 IE/ml - Durchstichflaschen
    • France (FR)
      Ultratard
    • Spain (ES)
      Ultratard
    • Portugal (PT)
      Ultratard
    • Italy (IT)
      Ultratard
    • Greece (GR)
      Ultratard
    • Sweden (SE)
      Ultratard
    • Finland (FI)
      Ultratard
许可日期2008/04/05
最近更新日期2012/08/10
药物ATC编码
    • A10AE01 insulin (human)
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase